Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	指定難病告示番号
1	(-)-epicatechin	Epicatechin	-	-	-	2件: 86, 113 💬
2	(pyr1)apelin-13	-	-	-	-	1件: 86 💬
3	(s)-2-(4,6-dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropanoic acid	-	-	-	-	1件: 86 💬
4	(s)-3-((3-(1-((6-(3,4-dimethoxyphenyl)pryazin-2-yl)amino)ethyl)phenyl)carbamoyl)-5-methylpridin-1-ium	-	-	-	-	1件: 86 💬
5	**comment**- imp inhalation solution identical to ventavis inhalation solution, but imp is in a different volume presentation. please see covering letter.	-	-	-	-	1件: 86 💬
6	10-nitro-9(e)-octadec-9-enoic acid	-	-	-	-	1件: 86 💬
7	11c-acetate	Acetate	-	-	-	3件: 13, 86, 88 💬
8	120 mg sodium nitrite inhalation solution	Nitrite	-	-	-	1件: 86 💬
9	15 mg sodium nitrite inhalation solution	Nitrite	-	-	-	1件: 86 💬
10	150mg cxa-10	CXA-10	-	-	-	1件: 86 💬
11	171	-	-	-	-	1件: 86 💬
12	2-(4-[5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy)-n-(methylsulfonyl)actamide	-	-	-	-	1件: 86 💬
13	2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-n-(methylsulfonyl) acetamide	Acetamide	-	-	-	1件: 86 💬
14	20 mg sildenafil citrate by mouth	Sildenafil	2件: D02229, D08514 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	1件: 86 💬
15	25% mtd sodium nitrite inhalation solution	Nitrite	-	-	-	1件: 86 💬
16	45 mg sodium nitrite inhalation solution	Nitrite	-	-	-	1件: 86 💬
17	4au76	-	-	-	-	1件: 86 💬
18	66215-101	-	-	-	-	1件: 86 💬
19	6r-bh4	Sapropterin	1件: D08505 💬	-	-	3件: 86, 124, 240 💬
20	75mg cxa-10	CXA-10	-	-	-	1件: 86 💬
21	90 mg sodium nitrite inhalation solution	Nitrite	-	-	-	1件: 86 💬
22	: 2-{4-[(5,6-difenilpirazin-2-yl)(isopropil)amino]butoxi}-n-	-	-	-	-	1件: 86 💬
23	[11c]-gsk2256098 500 mbq	GSK2256098	-	-	-	1件: 86 💬
24	[18f] fes	-	-	-	-	1件: 86 💬
25	[18f]fluoro-2-deoxy-2-d-glucose	D-glucose	1件: D00009 💬	-	-	2件: 86, 88 💬
26	Abi-009, nab-rapamycin, albumin-bound rapamycin	Sirolimus	1件: D00753 💬	1件: MTOR 💬	50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway	1件: 86 💬
27	Access program - sildenafil citrate, viagra, revatio	Sildenafil	2件: D02229, D08514 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	1件: 86 💬
28	Ace-011	-	-	-	-	1件: 86 💬
29	Acetamide	Acetamide	-	-	-	1件: 86 💬
30	Acetaminophen	Acetaminophen	1件: D00217 💬	2件: PTGS1, PTGS2 💬	23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	14件: 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
31	Acetate	Acetate	-	-	-	43件:  1 ,  2 ,  6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬
32	Act - 064992	-	-	-	-	1件: 86 💬
33	Act-050089	-	-	-	-	1件: 86 💬
34	Act-050089 (ro 61-0612)	-	-	-	-	1件: 86 💬
35	Act-064992	-	-	-	-	5件: 51, 85, 86, 88, 210 💬
36	Act-064992d	-	-	-	-	1件: 86 💬
37	Act-178418	-	-	-	-	1件: 86 💬
38	Act-293987	-	-	-	-	3件: 51, 86, 88 💬
39	Act-293987 (ns-304)	-	-	-	-	1件: 86 💬
40	Act-385781a	-	-	-	-	1件: 86 💬
41	Act-385781a (actelion epoprostenol)	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
42	Actriia-igg1fc	-	-	-	-	1件: 86 💬
43	Adcirca	-	-	-	-	1件: 86 💬
44	Adcirca 20 mg film-coated tablets	-	-	-	-	1件: 86 💬
45	Adcirca®	-	-	-	-	1件: 86 💬
46	Adempas	-	-	-	-	5件: 51, 86, 88, 225, 299 💬
47	Adempas (riociguat, bay63-2521)	Riociguat	1件: D09572 💬	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	2件: 86, 88 💬
48	Adempas - 0,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse	-	-	-	-	1件: 86 💬
49	Adempas - 1 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse	-	-	-	-	2件: 51, 86 💬
50	Adempas - 1,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse	-	-	-	-	2件: 51, 86 💬
51	Adempas - 2 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse	-	-	-	-	2件: 51, 86 💬
52	Adempas - 2,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse	-	-	-	-	2件: 51, 86 💬
53	Adempas 0.5 mg	-	-	-	-	2件: 86, 299 💬
54	Adempas 0.5 mg film coated tablet	-	-	-	-	1件: 86 💬
55	Adempas 1 mg film coated tablet	-	-	-	-	1件: 86 💬
56	Adempas 1.0 mg	-	-	-	-	2件: 86, 299 💬
57	Adempas 1.5 mg	-	-	-	-	1件: 86 💬
58	Adempas 1.5 mg film coated tablet	-	-	-	-	1件: 86 💬
59	Adempas 2 mg film coated tablet	-	-	-	-	1件: 86 💬
60	Adempas 2.0 mg	-	-	-	-	2件: 86, 299 💬
61	Adempas 2.5 mg	-	-	-	-	1件: 86 💬
62	Adempas 2.5 mg film coated tablet	-	-	-	-	1件: 86 💬
63	Adempas®	-	-	-	-	2件: 86, 88 💬
64	Adempas® 0.5 mg film-coated tablets	-	-	-	-	1件: 86 💬
65	Adempas® 1.0 mg film-coated tablets	-	-	-	-	1件: 86 💬
66	Adempas® 1.5 mg film-coated tablets	-	-	-	-	1件: 86 💬
67	Adempas® 2.0 mg film-coated tablets	-	-	-	-	1件: 86 💬
68	Adempas® 2.5 mg film-coated tablets	-	-	-	-	1件: 86 💬
69	Adempas¿ 0.5 mg compressa rivestita con film	-	-	-	-	1件: 86 💬
70	Adempas¿ 1.0	-	-	-	-	1件: 86 💬
71	Adempas¿ 1.5 mg	-	-	-	-	1件: 86 💬
72	Adempas¿ 2.0 mg	-	-	-	-	1件: 86 💬
73	Adempas¿ 2.5 mg	-	-	-	-	1件: 86 💬
74	Adipose derived mesenchymal stem cells	-	-	-	-	1件: 86 💬
75	Aerosolized iloprost	Iloprost	1件: D02721 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
76	Air001	-	-	-	-	1件: 86 💬
77	Air001 (sodium nitrite inhalation solution)	Nitrite	-	-	-	1件: 86 💬
78	Air001 inhalation solution	-	-	-	-	1件: 86 💬
79	Air001 inhalation solution (expansion arm)	-	-	-	-	1件: 86 💬
80	Al	-	-	-	-	9件:  5 ,  6 ,  7 , 28, 51, 67, 86, 114, 127 💬
81	Albuterol	Salbutamol	1件: D02147 💬	1件: ADRB2 💬	8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	8件: 12, 13, 86, 89, 113, 231, 256, 299 💬
82	Albuterol first	Salbutamol	1件: D02147 💬	1件: ADRB2 💬	8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
83	Albuterol.	Salbutamol	1件: D02147 💬	1件: ADRB2 💬	8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
84	Allogeneic human cardiosphere-derived stem cells	-	-	-	-	1件: 86 💬
85	Ambrisentan	Ambrisentan	1件: D07077 💬	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	7件: 51, 84, 85, 86, 88, 210, 211 💬
86	Ambrisentan - high dose	Ambrisentan	1件: D07077 💬	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
87	Ambrisentan - low dose	Ambrisentan	1件: D07077 💬	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
88	Ambrisentan 5 mg film-coated tablets	Ambrisentan	1件: D07077 💬	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
89	Ambrisentan 5mg film-coated tablets [marketed product]	Ambrisentan	1件: D07077 💬	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
90	Ambrisentan plus spironolactone	Ambrisentan	2件: D00443, D07077 💬	2件: EDNRA, NR3C2 💬	8件: Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
91	Ambrisentan tablet	Ambrisentan	1件: D07077 💬	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
92	Ammonia	Ammonia	1件: D02916 💬	-	-	4件:  6 , 17, 86, 88 💬
93	Amn107	-	-	-	-	2件: 34, 86 💬
94	Anakinra	Anakinra	1件: D02934 💬	2件: IL1R1, IL1R2 💬	15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer	17件:  2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 💬
95	Anastrozole	Anastrozole	1件: D00960 💬	1件: CYP19A1 💬	3件: Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis	3件: 78, 86, 193 💬
96	Angiotensin	Angiotensin II	2件: D00150, D02014 💬	2件: AGTR1, AGTR2 💬	16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	7件: 17, 19, 46, 66, 86, 222, 224 💬
97	Apabetalone	Apabetalone	1件: D11131 💬	-	-	1件: 86 💬
98	Apd811	-	-	-	-	1件: 86 💬
99	Apelin	-	-	-	-	1件: 86 💬
100	Apn01	Recombinant Human Angiotensin-Converting Enzyme 2	-	-	-	1件: 86 💬
101	Ar392830	-	-	-	-	1件: 86 💬
102	Aspirin	Acetylsalicylic acid	1件: D00109 💬	2件: PTGS1, PTGS2 💬	23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	11件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 210, 231 💬
103	Assigned pulmonary hypertension medication	-	-	-	-	1件: 86 💬
104	Autologous epcs transfected	-	-	-	-	1件: 86 💬
105	Autologous epcs transfected with human enos	-	-	-	-	1件: 86 💬
106	Aviptadil	Aviptadil	-	-	-	4件: 49, 51, 85, 86 💬
107	Azd4831	-	-	-	-	1件: 86 💬
108	Bardoxolone	Bardoxolone	1件: D09584 💬	-	-	7件: 66, 67, 84, 85, 86, 218, 222 💬
109	Bardoxolone methyl	Bardoxolone	2件: D09584, D09585 💬	-	-	7件: 66, 67, 84, 85, 86, 218, 222 💬
110	Bardoxolone methyl capsules	Bardoxolone	2件: D09584, D09585 💬	-	-	4件: 66, 67, 86, 222 💬
111	Bardoxolone methyl, cddo-me, cddo-methyl ester, nsc 713200, chemical name: oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-, methyl ester	Bardoxolone	2件: D09584, D09585 💬	-	-	1件: 86 💬
112	Bay 63-2521	-	-	-	-	2件: 86, 88 💬
113	Bay 63-2521 0.06 %	-	-	-	-	1件: 86 💬
114	Bay 63-2521 0.3 %	-	-	-	-	1件: 86 💬
115	Bay 63-2521 coated tablets 0.5 mg	-	-	-	-	2件: 86, 88 💬
116	Bay 63-2521 coated tablets 1 mg	-	-	-	-	2件: 86, 88 💬
117	Bay 63-2521 coated tablets 1.5 mg	-	-	-	-	2件: 86, 88 💬
118	Bay 63-2521 coated tablets 2 mg	-	-	-	-	2件: 86, 88 💬
119	Bay 63-2521 coated tablets 2.5 mg	-	-	-	-	2件: 86, 88 💬
120	Bay 63-2521 ir tablets 0.5 mg	-	-	-	-	1件: 86 💬
121	Bay 63-2521 ir tablets 1 mg	-	-	-	-	1件: 86 💬
122	Bay 63-2521 ir tablets 1.0 mg	-	-	-	-	1件: 86 💬
123	Bay 63-2521 ir tablets 1.5 mg	-	-	-	-	1件: 86 💬
124	Bay 63-2521 ir tablets 2.0 mg	-	-	-	-	1件: 86 💬
125	Bay 63-2521 ir tablets 2.5 mg	-	-	-	-	1件: 86 💬
126	Bay 63-2521 tablet	-	-	-	-	1件: 86 💬
127	Bay 63-2521 tablets 0.5 mg	-	-	-	-	2件: 86, 88 💬
128	Bay 63-2521 tablets 1 mg	-	-	-	-	2件: 86, 88 💬
129	Bay 63-2521 tablets 1.5 mg	-	-	-	-	2件: 86, 88 💬
130	Bay 63-2521 tablets 2 mg	-	-	-	-	2件: 86, 88 💬
131	Bay 63-2521 tablets 2.5 mg	-	-	-	-	2件: 86, 88 💬
132	Bay q 6256	-	-	-	-	1件: 86 💬
133	Bay1237592	-	-	-	-	2件: 86, 88 💬
134	Bay63-2521	-	-	-	-	3件: 51, 86, 299 💬
135	Beetroot juice	-	-	-	-	1件: 86 💬
136	Benzbromaron	-	-	-	-	1件: 86 💬
137	Benzbromaron al	-	-	-	-	1件: 86 💬
138	Benzbromarone	Benzbromarone	1件: D01056 💬	-	-	1件: 86 💬
139	Beraprost	Beraprost	1件: D02720 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
140	Beraprost sodium	Beraprost	1件: D02720 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
141	Beraprost sodium 314d modified release tablets	Beraprost	1件: D02720 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
142	Beraprost sodium modified release	Beraprost	1件: D02720 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
143	Bevacizumab	Bevacizumab	1件: D06409 💬	1件: VEGFA 💬	22件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway	9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
144	Bh4	-	-	-	-	5件: 51, 86, 124, 240, 299 💬
145	Bia	BIA	-	-	-	2件:  6 , 86 💬
146	Bia 5-1058	BIA	-	-	-	1件: 86 💬
147	Bia-5-1058	BIA	-	-	-	1件: 86 💬
148	Biological dmards	-	-	-	-	1件: 86 💬
149	Bisoprolol	Bisoprolol	2件: D00634, D02342 💬	1件: ADRB1 💬	10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	3件: 67, 86, 113 💬
150	Blood test	-	-	-	-	5件: 36, 86, 113, 162, 299 💬
151	Bosentan	Bosentan	2件: D01227, D07538 💬	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
152	Bosentan administration	Bosentan	2件: D01227, D07538 💬	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
153	Bosentan and sildenafil	Bosentan	4件: D01227, D02229, D07538, D08514 💬	3件: EDNRA, EDNRB, PDE5A 💬	11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
154	Bosentan monohidrato	Bosentan	2件: D01227, D07538 💬	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
155	Bosentan monohydrat	Bosentan	2件: D01227, D07538 💬	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
156	Bosentan monohydrate	Bosentan	2件: D01227, D07538 💬	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	4件: 51, 84, 86, 88 💬
157	Bosentan, ambrisentan	Ambrisentan	3件: D01227, D07077, D07538 💬	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
158	Bps-314d-mr	-	-	-	-	1件: 86 💬
159	Bps-mr	-	-	-	-	1件: 86 💬
160	Bromure d'ipratropium	Ipratropium	1件: D02212 💬	5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬	13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway	1件: 86 💬
161	Bsf 208075	-	-	-	-	1件: 86 💬
162	Bsf 208075 or lu 208075	-	-	-	-	1件: 86 💬
163	C07ab07	-	-	-	-	1件: 86 💬
164	C225	-	-	-	-	2件: 51, 86 💬
165	Capsaicin	Capsaicin	1件: D00250 💬	1件: TRPV1 💬	2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction	5件:  2 ,  6 , 19, 86, 226 💬
166	Captopril	Captopril	1件: D00251 💬	1件: ACE 💬	6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system	2件: 17, 86 💬
167	Carbon	Activated charcoal	1件: D03251 💬	-	-	9件:  6 , 46, 50, 51, 85, 86, 96, 97, 298 💬
168	Carbon monoxide	Activated charcoal	2件: D03251, D09706 💬	-	-	3件: 85, 86, 298 💬
169	Carvedilol	Carvedilol	2件: D00255, D03415 💬	5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬	12件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	5件:  6 , 57, 86, 113, 210 💬
170	Cetuximab	Cetuximab	1件: D03455 💬	1件: EGFR 💬	46件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis	5件: 34, 51, 86, 89, 331 💬
171	Chlorhexidine	Chlorhexidine	4件: D00858, D01345, D03463, D07668 💬	-	-	2件: 86, 299 💬
172	Cialis	-	-	-	-	2件: 51, 86 💬
173	Cialis 10 mg film-coated tablets	-	-	-	-	2件: 86, 113 💬
174	Cialis 2.5 mg film-coated tablets	-	-	-	-	2件: 86, 113 💬
175	Cialis 20 mg comprimidos recubiertos con película	-	-	-	-	1件: 86 💬
176	Cialis 20 mg film-coated tablets	-	-	-	-	2件: 86, 113 💬
177	Cialis 5 mg film-coated tablets	-	-	-	-	2件: 86, 113 💬
178	Cicletanine	Cicletanine	1件: D03487 💬	-	-	1件: 86 💬
179	Cicletanine hydrochloride	Cicletanine	1件: D03487 💬	-	-	1件: 86 💬
180	Citrulline	Citrulline	1件: D07706 💬	-	-	2件: 86, 113 💬
181	Cjnj-68150420-zzz-g001 (act- 064992d)	-	-	-	-	1件: 86 💬
182	Cjnj-68150420-zzz-g001 (act-064992d)	-	-	-	-	1件: 86 💬
183	Cjnj-68150420-zzz-g001(act-064992d)	-	-	-	-	1件: 86 💬
184	Clopidogrel	Clopidogrel	4件: D00769, D07729, D10823, D10824 💬	1件: P2RY12 💬	1件: Platelet activation	2件: 49, 86 💬
185	Coenzyme q-10	Ubidecarenone	1件: D01065 💬	-	-	1件: 86 💬
186	Coenzyme q-10 in normal control subjects	Ubidecarenone	1件: D01065 💬	-	-	1件: 86 💬
187	Coenzyme q-10 in pulmonary hypertension subjects	Ubidecarenone	1件: D01065 💬	-	-	1件: 86 💬
188	Combination product: device: axially oscillating sphere dry powder inhaler (aos dpi)	-	-	-	-	1件: 86 💬
189	Combination product: implantable system for remodulin (treprostinil)	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
190	Combination product: treprostinil via implanted pump	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
191	Commercial ventavis® (iloprost)	Iloprost	1件: D02721 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
192	Conivaptan	Conivaptan	2件: D01236, D07748 💬	2件: AVPR1A, AVPR2 💬	5件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption	1件: 86 💬
193	Conventional drug therapy(expectorant,bronchodilator)	-	-	-	-	1件: 86 💬
194	Cosmofer	-	-	-	-	3件: 86, 96, 97 💬
195	Current marketed flolan (epoprostenol sodium)	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
196	Cxa-10	CXA-10	-	-	-	2件: 86, 222 💬
197	D-glucose	D-glucose	1件: D00009 💬	-	-	3件: 49, 86, 88 💬
198	Device: breelib nebulizer	-	-	-	-	1件: 86 💬
199	Device: crono five ambulatory pump	-	-	-	-	1件: 86 💬
200	Device: endopat measurement	-	-	-	-	1件: 86 💬
201	Device: generic dry powder inhaler	-	-	-	-	1件: 86 💬
202	Device: i-neb aad system	-	-	-	-	1件: 86 💬
203	Device: l606 inhalation system	-	-	-	-	1件: 86 💬
204	Device: mhealth intervention	-	-	-	-	1件: 86 💬
205	Device: usual care	-	-	-	-	1件: 86 💬
206	Dhea	Prasterone	1件: D08409 💬	3件: AR, ESR1, ESR2 💬	11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway	3件: 49, 86, 96 💬
207	Dhea tablet	Prasterone	1件: D08409 💬	3件: AR, ESR1, ESR2 💬	11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway	1件: 86 💬
208	Diagnostic test: cardiac mri (gadolinium enhanced)	Gadolinium	-	-	-	1件: 86 💬
209	Diagnostic test: cmri	-	-	-	-	2件: 51, 86 💬
210	Diagnostic test: endogenous thrombin potential	Thrombin	1件: D00090 💬	-	-	2件: 86, 88 💬
211	Diagnostic test: light transmission aggregometry	-	-	-	-	2件: 86, 88 💬
212	Diagnostic test: pet-ct imaging with [89zr]-bevacizumab	Bevacizumab	1件: D06409 💬	1件: VEGFA 💬	22件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway	1件: 86 💬
213	Diagnostic test: platelet function analyzer-100	-	-	-	-	2件: 86, 88 💬
214	Diagnostic test: rotational thromboelastometry	-	-	-	-	2件: 86, 88 💬
215	Dichloroacetate	Dichloroacetic acid	-	-	-	1件: 86 💬
216	Dichloroacetate sodium	Dichloroacetic acid	-	-	-	1件: 86 💬
217	Dietanolamina de treprostinilo	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
218	Diltiazem	Diltiazem	3件: D00616, D03830, D07845 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	3件: 51, 58, 86 💬
219	Diltiazem hydrochloride	Diltiazem	3件: D00616, D03830, D07845 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
220	Dimethyl fumarate	Dimethyl fumarate	1件: D03846 💬	1件: KEAP1 💬	4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis	4件: 13, 51, 86, 296 💬
221	Dimethyl fumarate (dmf)	Dimethyl fumarate	1件: D03846 💬	1件: KEAP1 💬	4件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis	3件: 13, 51, 86 💬
222	Diphenhydramine	Diphenhydramine	6件: D00300, D00669, D02419, D03285, D03360, D03854 💬	1件: HRH1 💬	3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction	8件: 11, 49, 51, 70, 86, 96, 222, 256 💬
223	Duo-therapy with sildenafil + bosentan	Bosentan	4件: D01227, D02229, D07538, D08514 💬	3件: EDNRA, EDNRB, PDE5A 💬	11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
224	Efi/act-385781a	-	-	-	-	1件: 86 💬
225	Elafin	Elafin	-	-	-	1件: 86 💬
226	Endothelin receptor antagonist therapy	-	-	-	-	1件: 86 💬
227	Endothelin-3	-	-	-	-	1件: 86 💬
228	Enos transfected epcs will be delivered via a pa line	-	-	-	-	1件: 86 💬
229	Epicatechin	Epicatechin	-	-	-	2件: 86, 113 💬
230	Epoprostenol	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
231	Epoprostenol for injection	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
232	Epoprostenol sodico	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
233	Epoprostenol sodium	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
234	Epoprostenol-actelion	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
235	Epoprostenolo per iniezione	-	-	-	-	1件: 86 💬
236	Equal	-	-	-	-	5件:  6 , 13, 67, 86, 230 💬
237	Era and pde-5i (sildenafil, tadalafil, bosentan, macitentan)	Bosentan	6件: D01227, D02008, D02229, D07538, D08514, D10135 💬	3件: EDNRA, EDNRB, PDE5A 💬	11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
238	Era as specific pah treatment	-	-	-	-	1件: 86 💬
239	Erbitux	-	-	-	-	2件: 51, 86 💬
240	Esomeprazole	Esomeprazole	4件: D01984, D04056, D07917, D09339 💬	2件: ATP4A, ATP4B 💬	4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation	6件: 13, 46, 86, 98, 298, 299 💬
241	Esr-specific pet scan	-	-	-	-	1件: 86 💬
242	Esuberaprost	-	-	-	-	1件: 86 💬
243	Eutonic treprostinil solution	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
244	Famotidine	Famotidine	1件: D00318 💬	1件: HRH2 💬	3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction	4件:  6 , 46, 86, 98 💬
245	Famotidine 20 mg	Famotidine	1件: D00318 💬	1件: HRH2 💬	3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction	1件: 86 💬
246	Fdc macitentan/tadalafil	Macitentan	2件: D02008, D10135 💬	3件: EDNRA, EDNRB, PDE5A 💬	11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
247	Ferinject	-	-	-	-	2件: 86, 299 💬
248	Ferinject or cosmofer	-	-	-	-	1件: 86 💬
249	Ferric carboxymaltose	Ferric carboxymaltose	1件: D08920 💬	-	-	4件: 86, 96, 97, 299 💬
250	Ferricarboxymaltose	-	-	-	-	1件: 86 💬
251	Fk506 level 2-3 ng/ml	-	-	-	-	1件: 86 💬
252	Fk506 level 3-5 ng/ml	-	-	-	-	1件: 86 💬
253	Fk506 level < 2 ng/ml	-	-	-	-	1件: 86 💬
254	Flolan	-	-	-	-	1件: 86 💬
255	Flolan injection with currently marketed diluent	-	-	-	-	1件: 86 💬
256	Flolan injection with reformulated diluent	-	-	-	-	1件: 86 💬
257	Flolan tm and glycine diluent	Glycine	1件: D00011 💬	-	-	1件: 86 💬
258	Flolan®	-	-	-	-	1件: 86 💬
259	Flolan™ and glycine diluent	Glycine	1件: D00011 💬	-	-	1件: 86 💬
260	Fluoxetine	Fluoxetine	2件: D00326, D00823 💬	1件: SLC6A4 💬	2件: Serotonergic synapse, Synaptic vesicle cycle	4件: 13, 17, 78, 86 💬
261	Fulvestrant	Fulvestrant	1件: D01161 💬	2件: ESR1, ESR2 💬	9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway	1件: 86 💬
262	G04be03	-	-	-	-	1件: 86 💬
263	G04be03- sildenafil - sildenafil (citrato)	Sildenafil	2件: D02229, D08514 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	1件: 86 💬
264	Gadolinium	Gadolinium	-	-	-	6件: 13, 34, 46, 58, 65, 86 💬
265	Gb002	-	-	-	-	1件: 86 💬
266	Gb002 capsules	-	-	-	-	1件: 86 💬
267	Glivec	-	-	-	-	2件: 51, 86 💬
268	Glivec 100 mg comprimidos recubiertos con película	-	-	-	-	2件: 34, 86 💬
269	Glivec 100 mg filmtabletten	-	-	-	-	2件: 51, 86 💬
270	Glivec 100 mg hartkapsel	-	-	-	-	1件: 86 💬
271	Glivec®	-	-	-	-	1件: 86 💬
272	Glivec® 100 mg filmtabletten	-	-	-	-	1件: 86 💬
273	Glucose	Dextrose, unspecified form	-	-	-	15件:  2 ,  6 , 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬
274	Glycine	Glycine	1件: D00011 💬	-	-	5件: 35, 60, 86, 226, 299 💬
275	Gma301 injection	-	-	-	-	1件: 86 💬
276	Gold	Gold	-	-	-	38件:  2 ,  5 ,  6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬
277	Gradient	-	-	-	-	4件: 58, 86, 149, 215 💬
278	Gs-4997 18 mg	-	-	-	-	1件: 86 💬
279	Gs-4997 2 mg	-	-	-	-	1件: 86 💬
280	Gs-4997 6 mg	-	-	-	-	1件: 86 💬
281	Gsk1325760	-	-	-	-	2件: 86, 88 💬
282	Gsk1325760a	-	-	-	-	1件: 86 💬
283	Gsk2256098	GSK2256098	-	-	-	1件: 86 💬
284	Gsk2586881	-	-	-	-	1件: 86 💬
285	Hgp1206	-	-	-	-	1件: 86 💬
286	Hydroxyurea	Hydroxyurea	1件: D00341 💬	1件: RRM2 💬	6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway	8件:  3 , 13, 19, 20, 65, 85, 86, 284 💬
287	Hypotonictreprostinil solution	-	-	-	-	1件: 86 💬
288	I.v. selexipag	Selexipag	1件: D09994 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
289	Ifetroban	Ifetroban	1件: D04500 💬	1件: TBXA2R 💬	3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation	3件: 51, 86, 113 💬
290	Ilomedin 20	-	-	-	-	1件: 86 💬
291	Ilomedin 20 [20 µg / ml]	-	-	-	-	1件: 86 💬
292	Iloprost	Iloprost	1件: D02721 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	4件: 51, 84, 85, 86 💬
293	Iloprost (5 µg)	Iloprost	1件: D02721 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
294	Iloprost (ventavis bayq6256)	Iloprost	1件: D02721 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
295	Iloprost (ventavis inhaled, bayq6256)	Iloprost	1件: D02721 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
296	Iloprost (ventavis, bayq 6256)	Iloprost	1件: D02721 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
297	Iloprost (ventavis, bayq6256)	Iloprost	1件: D02721 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
298	Iloprost (ventavis®)	Iloprost	1件: D02721 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
299	Iloprost inhalation solution (ventavis)	Iloprost	1件: D02721 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	2件: 85, 86 💬
300	Iloprost pd-15	Iloprost	1件: D02721 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
301	Iloprost pd-6	Iloprost	1件: D02721 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
302	Iloprost,(ventavis, bayq6256)	Iloprost	1件: D02721 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
303	Imatinib	Imatinib	2件: D01441, D08066 💬	3件: ABL1, KIT, PDGFRA 💬	31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis	12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
304	Imatinib mesilate	Imatinib	2件: D01441, D08066 💬	3件: ABL1, KIT, PDGFRA 💬	31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis	3件: 13, 86, 88 💬
305	Imatinib mesylate	Imatinib	2件: D01441, D08066 💬	3件: ABL1, KIT, PDGFRA 💬	31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis	5件: 13, 28, 34, 51, 86 💬
306	Inhaled dry powder treprostinil (liq861)	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
307	Inhaled iloprost (5 µg)	Iloprost	1件: D02721 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
308	Inhaled iloprost (ventavis, bayq6256)	Iloprost	1件: D02721 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
309	Inhaled nitric oxide	Nitric Oxide	1件: D00074 💬	-	-	2件: 85, 86 💬
310	Inhaled nitric oxide & inopulse delivery	Nitric Oxide	1件: D00074 💬	-	-	1件: 86 💬
311	Inhaled nitric oxide 75 mcg/kg ibw/hr	Nitric Oxide	1件: D00074 💬	-	-	2件: 85, 86 💬
312	Inhaled no with pulsed delivery	-	-	-	-	1件: 86 💬
313	Inhaled prostacyclin	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
314	Inhaled treprostinil	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	2件: 84, 86 💬
315	Ino	-	-	-	-	2件: 85, 86 💬
316	Intravenous administration of ferric carboxymaltose	Ferric carboxymaltose	1件: D08920 💬	-	-	1件: 86 💬
317	Intravenous treprostinil	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
318	Intravenous/subcutaneous treprostinil	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
319	Ipratropium	Ipratropium	1件: D02212 💬	5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬	13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway	2件:  6 , 86 💬
320	Iron supplement	-	-	-	-	1件: 86 💬
321	Jnj-67896049	-	-	-	-	1件: 86 💬
322	Jnj-67896049 (act-293987)	-	-	-	-	1件: 86 💬
323	Jnj-67896062 / act-064992	-	-	-	-	2件: 86, 88 💬
324	Jtt-251	-	-	-	-	1件: 86 💬
325	Kar5585 capsules	-	-	-	-	1件: 86 💬
326	L-citrulline malate	Citrulline	1件: D07706 💬	-	-	1件: 86 💬
327	L606 (liposomal treprostinil) inhalation solution 51ug	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
328	Levitra	-	-	-	-	2件: 13, 86 💬
329	Lidocaine	Lidocaine	3件: D00358, D02086, D08127 💬	5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction	10件:  6 , 13, 34, 46, 51, 86, 168, 226, 231, 256 💬
330	Liq861 100 µg	-	-	-	-	1件: 86 💬
331	Liq861 106 µg	-	-	-	-	1件: 86 💬
332	Liq861 25 µg	-	-	-	-	1件: 86 💬
333	Liq861 26.5 µg	-	-	-	-	1件: 86 💬
334	Liq861 50 µg	-	-	-	-	1件: 86 💬
335	Liq861 53 µg	-	-	-	-	1件: 86 💬
336	Liq861 75 µg	-	-	-	-	1件: 86 💬
337	Liq861 79.5 µg	-	-	-	-	1件: 86 💬
338	Liq861 inhaled treprostinil	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
339	Lisuride	Lisuride	2件: D01462, D08132 💬	3件: DRD2, DRD3, DRD4 💬	8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	2件:  6 , 86 💬
340	Lloprost(ventavis,bayq6252, 10 µg/ml)	-	-	-	-	1件: 86 💬
341	Lloprost(ventavis,bayq6252, 20 µg/ml)	-	-	-	-	1件: 86 💬
342	Ly450190	-	-	-	-	1件: 86 💬
343	Macitentan	Macitentan	1件: D10135 💬	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	5件: 51, 85, 86, 88, 210 💬
344	Macitentan (act-064992)	Macitentan	1件: D10135 💬	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
345	Macitentan 10 mg	Macitentan	1件: D10135 💬	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	3件: 51, 86, 88 💬
346	Macitentan 10 mg tablet, once daily.	Macitentan	1件: D10135 💬	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
347	Macitentan 37.5 mg	Macitentan	1件: D10135 💬	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
348	Macitentan 75 mg	Macitentan	1件: D10135 💬	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
349	Macitentan group	Macitentan	1件: D10135 💬	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
350	Macitentan tablets	Macitentan	1件: D10135 💬	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	2件: 86, 88 💬
351	Md-711	-	-	-	-	1件: 86 💬
352	Medical air	Medical air	-	-	-	3件: 85, 86, 193 💬
353	Metformin	Metformin	2件: D00944, D04966 💬	2件: PRKAA1, PRKAA2 💬	19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway	21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
354	Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo	-	-	-	-	1件: 86 💬
355	Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo [3,4-b]pyridine-3-yl]-5-pyrimidinyl(methyl)carb	-	-	-	-	2件: 86, 88 💬
356	Methyl [4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1h-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]meth	-	-	-	-	2件: 86, 88 💬
357	Methylprednisolone	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	44件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
358	Mk-5475	-	-	-	-	1件: 86 💬
359	Mk-8892	-	-	-	-	1件: 86 💬
360	Monitor	Methamidophos	-	-	-	18件:  2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬
361	Mono-therapy with sildenafil	Sildenafil	2件: D02229, D08514 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	1件: 86 💬
362	Morphine	Morphine	3件: D00842, D02271, D08233 💬	1件: OPRM1 💬	3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction	5件: 36, 46, 70, 85, 86 💬
363	Morphine sulfate	Morphine	3件: D00842, D02271, D08233 💬	1件: OPRM1 💬	3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction	3件: 46, 85, 86 💬
364	Moxifloxacin	Moxifloxacin	2件: D00874, D08237 💬	-	-	8件:  2 ,  6 , 46, 49, 85, 86, 240, 299 💬
365	Moxifloxacin 400 mg	Moxifloxacin	2件: D00874, D08237 💬	-	-	1件: 86 💬
366	Multihance	-	-	-	-	2件: 86, 88 💬
367	Nebulized combination ipratropium bromide with salbutamol	Ipratropium	2件: D02147, D02212 💬	6件: ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬	17件: Adrenergic signaling in cardiomyocytes, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
368	Nebulized ipratropium bromide	Ipratropium	1件: D02212 💬	5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬	13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway	1件: 86 💬
369	New thermo stable formulation of epoprostenol sodium	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
370	Nicardipine	Nicardipine	2件: D00617, D08270 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	2件: 70, 86 💬
371	Nilotinib	Nilotinib	1件: D08953 💬	4件: ABL1, KIT, PDGFRA, PDGFRB 💬	32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis	5件:  6 ,  8 , 34, 51, 86 💬
372	Nilotinib 50 mg	Nilotinib	1件: D08953 💬	4件: ABL1, KIT, PDGFRA, PDGFRB 💬	32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis	1件: 86 💬
373	Nitric oxide	Nitric Oxide	1件: D00074 💬	-	-	8件: 46, 85, 86, 98, 210, 251, 294, 299 💬
374	Nitric oxide for inhalation	Nitric Oxide	1件: D00074 💬	-	-	2件: 86, 299 💬
375	Nitric oxide generated by the geno nitrosyl delivery system	Nitric Oxide	1件: D00074 💬	-	-	1件: 86 💬
376	Nitric oxide plus oxygen	Nitric Oxide	2件: D00003, D00074 💬	-	-	1件: 86 💬
377	Nitrite	Nitrite	-	-	-	2件: 86, 299 💬
378	Nitrosyl	Nitric Oxide	1件: D00074 💬	-	-	1件: 86 💬
379	Non-biologic dmards	-	-	-	-	2件: 46, 86 💬
380	Ns-304	-	-	-	-	3件: 70, 86, 88 💬
381	Null	-	-	-	-	16件:  6 , 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬
382	Nx1011	-	-	-	-	1件: 86 💬
383	Observational study with patients treated with tracleer, ventavis, veletri, opsumit and/or uptravi	-	-	-	-	1件: 86 💬
384	Olaparib	Olaparib	1件: D09730 💬	2件: PARP1, PARP2 💬	5件: Apoptosis, Base excision repair, Diabetic cardiomyopathy, NF-kappa B signaling pathway, Necroptosis	2件: 86, 285 💬
385	Opsumit	-	-	-	-	3件: 86, 88, 210 💬
386	Opsumit (macitentan)	Macitentan	1件: D10135 💬	2件: EDNRA, EDNRB 💬	9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
387	Opsumit®	-	-	-	-	3件: 86, 88, 210 💬
388	Oral anticoagulant treatment	-	-	-	-	1件: 86 💬
389	Oral era	-	-	-	-	1件: 86 💬
390	Oral ifetroban	Ifetroban	1件: D04500 💬	1件: TBXA2R 💬	3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation	2件: 51, 86 💬
391	Oral pde5 inhibitors	-	-	-	-	1件: 86 💬
392	Oral selexipag (uptravi)	Selexipag	1件: D09994 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
393	Oral sildenafil	Sildenafil	2件: D02229, D08514 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	1件: 86 💬
394	Oral treprostinil	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	2件: 51, 86 💬
395	Oral treprostinil (ut-15c) sustained release tablets	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
396	Other: iloprost (ventavis inhaled, bayq6256)	Iloprost	1件: D02721 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
397	Other: noninvasive actigraphy monitor	Methamidophos	-	-	-	1件: 86 💬
398	Other: oxygen supplementation	Oxygen	1件: D00003 💬	-	-	1件: 86 💬
399	Other: standard-of-care	-	-	-	-	1件: 86 💬
400	Other: standardized meals	-	-	-	-	1件: 86 💬
401	Other: subacute hypoxic exposures	-	-	-	-	1件: 86 💬
402	Oxygen	Oxygen	1件: D00003 💬	-	-	18件:  6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬
403	Oxygen supplementation	Oxygen	1件: D00003 💬	-	-	1件: 86 💬
404	Oxygen, liquid	Oxygen	1件: D00003 💬	-	-	2件: 86, 88 💬
405	Pah	-	-	-	-	3件: 49, 53, 86 💬
406	Pah medication	-	-	-	-	1件: 86 💬
407	Parenteral remodulin (treprostinil) injection	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
408	Pb1046	-	-	-	-	1件: 86 💬
409	Pb1046 subcutaneous injection	-	-	-	-	1件: 86 💬
410	Pb1046, vip-elp1-120, vasomera	-	-	-	-	1件: 86 💬
411	Pemziviptadil (pb1046)	-	-	-	-	1件: 86 💬
412	Pemziviptadil (pb1046) injection	-	-	-	-	1件: 86 💬
413	Pf-00489791	PF-00489791	-	-	-	1件: 86 💬
414	Ph-combination therapy	-	-	-	-	2件: 86, 88 💬
415	Ph-monotherapy	-	-	-	-	2件: 86, 88 💬
416	Pioglitazone	Pioglitazone	2件: D00945, D08378 💬	1件: PPARG 💬	9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer	17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
417	Placebo	-	-	-	-	26件:  3 ,  5 ,  6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬
418	Plx-pad	Placental Mesenchymal Stem Cells	-	-	-	1件: 86 💬
419	Prednisone	Prednisone	1件: D00473 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	47件:  2 ,  6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬
420	Procedure: b-lines se	-	-	-	-	3件: 58, 86, 215 💬
421	Procedure: coronary flow reserve se	-	-	-	-	3件: 58, 86, 215 💬
422	Procedure: diastolic function se	-	-	-	-	3件: 58, 86, 215 💬
423	Procedure: left ventricular contractile reserve se	-	-	-	-	3件: 58, 86, 215 💬
424	Procedure: left ventricular outflow tract gradient se	-	-	-	-	3件: 58, 86, 215 💬
425	Procedure: mitral regurgitation se	-	-	-	-	3件: 58, 86, 215 💬
426	Procedure: no gas	-	-	-	-	2件: 86, 88 💬
427	Procedure: padn	-	-	-	-	1件: 86 💬
428	Procedure: pulmonary hemodynamics se	-	-	-	-	3件: 58, 86, 215 💬
429	Procedure: sham padn	-	-	-	-	1件: 86 💬
430	Prostacyclin	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
431	Puri-nethol	-	-	-	-	3件: 86, 96, 97 💬
432	Q4w gma301 iv injections (1000 mg)	-	-	-	-	1件: 86 💬
433	Q4w gma301 iv injections (300 mg)	-	-	-	-	1件: 86 💬
434	Q4w gma301 iv injections (600 mg)	-	-	-	-	1件: 86 💬
435	Qcc374	-	-	-	-	1件: 86 💬
436	Qcc374 0.015 mg	-	-	-	-	1件: 86 💬
437	Qcc374 0.06 mg	-	-	-	-	1件: 86 💬
438	Qti571	-	-	-	-	1件: 86 💬
439	Qutenza	-	-	-	-	1件: 86 💬
440	Qutenza (8% capsaicin)	Capsaicin	1件: D00250 💬	1件: TRPV1 💬	2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction	1件: 86 💬
441	Radiation: pet/ct scan: two pet scans using 1. c-11 hed and 2. n-13 ammonia or rubidium-82	Ammonia	1件: D02916 💬	-	-	1件: 86 💬
442	Ralinepag	Ralinepag	1件: D10725 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
443	Ranolazine	Ranolazine	2件: D05700, D05701 💬	-	-	6件:  2 , 58, 86, 96, 113, 114 💬
444	Rapamycin	Sirolimus	1件: D00753 💬	1件: MTOR 💬	50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway	18件:  2 , 15, 34, 35, 46, 49, 51, 60, 61, 67, 86, 89, 96, 157, 158, 256, 278, 279 💬
445	Rapid dose titration group of subcutaneous treprostinil	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
446	Recombinant human angiotensin-converting enzyme 2	Angiotensin II	2件: D00150, D02014 💬	2件: AGTR1, AGTR2 💬	16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	1件: 86 💬
447	Recombinant human angiotensin-converting enzyme 2 (ace2), apn01	Angiotensin II	2件: D00150, D02014 💬	2件: AGTR1, AGTR2 💬	16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	1件: 86 💬
448	Remodulin	-	-	-	-	2件: 86, 88 💬
449	Remodulin (treprostinil sodium)	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
450	Remodulin® (treprostinil) 1 mg/ml solution for infusion	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
451	Remodulin® (treprostinil) 10 mg/ml solution for infusion	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
452	Remodulin® (treprostinil) 2.5 mg/ml solution for infusion	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
453	Remodulin® (treprostinil) 5 mg/ml solution for infusion	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
454	Revatio	-	-	-	-	3件: 85, 86, 113 💬
455	Revatio 10 mg/ml powder for oral suspension	-	-	-	-	1件: 86 💬
456	Revatio 20 mg film coated tablets	-	-	-	-	1件: 86 💬
457	Revatio 20 mg film-coated tablets	-	-	-	-	1件: 86 💬
458	Revatio 20 mg filmtabletten	-	-	-	-	1件: 86 💬
459	Revatio 20 mg, comprimidos recubiertos con película	-	-	-	-	1件: 86 💬
460	Revatio inyectable	-	-	-	-	1件: 86 💬
461	Revatio oral	-	-	-	-	1件: 86 💬
462	Revatio pos	-	-	-	-	1件: 86 💬
463	Revatio tablets	-	-	-	-	1件: 86 💬
464	Revatio ® 20 mg film-coated tablets	-	-	-	-	1件: 86 💬
465	Revatio®	-	-	-	-	1件: 86 💬
466	Riciguat group	-	-	-	-	1件: 86 💬
467	Rifampin	Rifampicin	1件: D00211 💬	-	-	5件:  6 , 13, 84, 86, 299 💬
468	Riociguat	Riociguat	1件: D09572 💬	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	6件: 51, 84, 86, 88, 225, 299 💬
469	Riociguat (adempas, bay63-2521)	Riociguat	1件: D09572 💬	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	4件: 51, 86, 88, 299 💬
470	Riociguat (bay63-2521)	Riociguat	1件: D09572 💬	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	1件: 86 💬
471	Riociguat granules 0.3% for oral application	Riociguat	1件: D09572 💬	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	1件: 86 💬
472	Riociguat oral product	Riociguat	1件: D09572 💬	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	1件: 86 💬
473	Riociguat pill	Riociguat	1件: D09572 💬	3件: GUCY1A1, GUCY1A2, GUCY1B1 💬	11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	1件: 86 💬
474	Ritonavir	Ritonavir	1件: D00427 💬	-	-	3件:  2 , 86, 265 💬
475	Rituximab	Rituximab	1件: D02994 💬	1件: MS4A1 💬	1件: Hematopoietic cell lineage	47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
476	Ro 47-0203	-	-	-	-	4件: 51, 85, 86, 88 💬
477	Ro 47-0203 / act-050088	-	-	-	-	1件: 86 💬
478	Ro-47-0203	-	-	-	-	1件: 86 💬
479	Ro-47-0203/029	-	-	-	-	1件: 86 💬
480	Ro47-0203	-	-	-	-	1件: 86 💬
481	Ro47-0203 / act-050088	-	-	-	-	2件: 51, 86 💬
482	Roactemra	-	-	-	-	9件: 40, 41, 46, 51, 86, 107, 266, 271, 331 💬
483	Rt234 - vardenafil inhalation powder	Vardenafil	3件: D02731, D03260, D08668 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	1件: 86 💬
484	Rta 402	-	-	-	-	3件: 67, 86, 218 💬
485	Rubidium	Rubidium	-	-	-	2件: 84, 86 💬
486	Rvg 33865	-	-	-	-	1件: 86 💬
487	Rvt-1201	-	-	-	-	1件: 86 💬
488	Salbutamol	Salbutamol	1件: D02147 💬	1件: ADRB2 💬	8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	9件:  3 , 11, 49, 85, 86, 111, 228, 256, 299 💬
489	Saline	-	-	-	-	10件:  6 , 13, 17, 53, 67, 78, 86, 97, 168, 299 💬
490	Sapropterin	Sapropterin	1件: D08505 💬	-	-	3件: 86, 124, 240 💬
491	Sapropterin dihydrochloride (6r-bh4)	Sapropterin	1件: D08505 💬	-	-	1件: 86 💬
492	Saquinavir	Saquinavir	2件: D00429, D01160 💬	-	-	2件: 86, 265 💬
493	Saquinavir and ritonavir	Ritonavir	3件: D00427, D00429, D01160 💬	-	-	1件: 86 💬
494	Sauerstoff	-	-	-	-	2件: 86, 88 💬
495	Selexipag	Selexipag	1件: D09994 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	5件: 51, 70, 84, 86, 88 💬
496	Selexipag (uptravi)	Selexipag	1件: D09994 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
497	Selexipag, act-293987 (ns-304)	Selexipag	1件: D09994 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
498	Selonsertib	Selonsertib	1件: D10988 💬	1件: MAP3K5 💬	17件: Alzheimer disease, Amyotrophic lateral sclerosis, Apoptosis, Fluid shear stress and atherosclerosis, Huntington disease, MAPK signaling pathway, Neurotrophin signaling pathway, Non-alcoholic fatty liver disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Platinum drug resistance, Protein processing in endoplasmic reticulum, Sphingolipid signaling pathway, Spinocerebellar ataxia, TNF signaling pathway, Thermogenesis, Tight junction	1件: 86 💬
499	Seralutinib	-	-	-	-	1件: 86 💬
500	Serine	Serine	1件: D00016 💬	-	-	3件:  2 ,  6 , 86 💬
501	Sham o2 (medical air)	Medical air	-	-	-	1件: 86 💬
502	Sildenaf	-	-	-	-	1件: 86 💬
503	Sildenafil	Sildenafil	2件: D02229, D08514 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
504	Sildenafil (as citrate)	Sildenafil	2件: D02229, D08514 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	1件: 86 💬
505	Sildenafil (revatio)	Sildenafil	2件: D02229, D08514 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	1件: 86 💬
506	Sildenafil (revatio) 20 mg tid	Sildenafil	2件: D02229, D08514 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	1件: 86 💬
507	Sildenafil 20mg	Sildenafil	2件: D02229, D08514 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	2件: 51, 86 💬
508	Sildenafil 20mg and bosentan 62.5mg	Bosentan	4件: D01227, D02229, D07538, D08514 💬	3件: EDNRA, EDNRB, PDE5A 💬	11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	2件: 51, 86 💬
509	Sildenafil citrate	Sildenafil	2件: D02229, D08514 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	4件: 51, 85, 86, 225 💬
510	Sildenafil citrate (uk-92,480)	Sildenafil	2件: D02229, D08514 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	1件: 86 💬
511	Sildenafil filmtabletten	Sildenafil	2件: D02229, D08514 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	1件: 86 💬
512	Sildenafil singly or in association with bosentan	Bosentan	4件: D01227, D02229, D07538, D08514 💬	3件: EDNRA, EDNRB, PDE5A 💬	11件: Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
513	Sildenafilo	Sildenafil	2件: D02229, D08514 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	1件: 86 💬
514	Simvastatin	Simvastatin	1件: D00434 💬	1件: HMGCR 💬	4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis	21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
515	Simvastatin 40 mg	Simvastatin	1件: D00434 💬	1件: HMGCR 💬	4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis	1件: 86 💬
516	Simvastatin 40 mg tablets	Simvastatin	1件: D00434 💬	1件: HMGCR 💬	4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis	1件: 86 💬
517	Sitaxentan	Sitaxentan	1件: D07171 💬	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
518	Sitaxentan sodium	Sitaxentan	1件: D07171 💬	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
519	Sitaxsentan	Sitaxentan	1件: D07171 💬	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
520	Sitaxsentan alone	Sitaxentan	1件: D07171 💬	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
521	Sitaxsentan and sildenafil	Sildenafil	3件: D02229, D07171, D08514 💬	2件: EDNRA, PDE5A 💬	9件: Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
522	Sitaxsentan sodium	Sitaxentan	1件: D07171 💬	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
523	Slow dose titration group of subcutaneous treprostinil	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
524	Sodium nitrite	Nitrite	-	-	-	2件: 86, 299 💬
525	Sodium nitrite inhalation solution	Nitrite	-	-	-	1件: 86 💬
526	Sodium tanshinone iia sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth	Dextrose, unspecified form	2件: D02229, D08514 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	1件: 86 💬
527	Sorafenib	Sorafenib	2件: D06272, D08524 💬	8件: BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬	87件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway	2件: 34, 86 💬
528	Sotatercept	Sotatercept	1件: D09670 💬	1件: ACVR2A 💬	4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway	2件: 86, 284 💬
529	Spironolactone	Spironolactone	1件: D00443 💬	1件: NR3C2 💬	1件: Aldosterone-regulated sodium reabsorption	7件: 58, 67, 86, 113, 210, 218, 225 💬
530	Spironolactone and conivaptan	Conivaptan	3件: D00443, D01236, D07748 💬	3件: AVPR1A, AVPR2, NR3C2 💬	6件: Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption	1件: 86 💬
531	Spironolactone captopril carvedilol	Captopril	4件: D00251, D00255, D00443, D03415 💬	7件: ACE, ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, NR3C2 💬	18件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
532	Sti571	-	-	-	-	2件: 51, 86 💬
533	Subcutaneous and intravenous prostacyclin	Epoprostenol	2件: D00106, D01337 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
534	Subcutaneous treprostinil	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
535	Sugar pill	-	-	-	-	8件:  5 ,  6 , 49, 67, 70, 86, 206, 210 💬
536	Sulfasalazine	Sulfasalazine	1件: D00448 💬	-	-	4件: 46, 86, 94, 271 💬
537	Sulfate	Sulfate ion	-	-	-	25件:  2 ,  6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬
538	Tadalafil	Tadalafil	1件: D02008 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	7件:  6 , 51, 75, 84, 86, 113, 210 💬
539	Tadalafil 20 mg film-coated tablets	Tadalafil	1件: D02008 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	1件: 86 💬
540	Tadalafil 40 mg	Tadalafil	1件: D02008 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	1件: 86 💬
541	Tadalafil and ambrisentan upfront combination therapy	Ambrisentan	2件: D02008, D07077 💬	2件: EDNRA, PDE5A 💬	9件: Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	2件: 51, 86 💬
542	Tadalafil oral suspension	Tadalafil	1件: D02008 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	1件: 86 💬
543	Tadalafil, placebo	Tadalafil	1件: D02008 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	1件: 86 💬
544	Tadalafil- tablet or oral suspension	Tadalafil	1件: D02008 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	1件: 86 💬
545	Tadalafilo	Tadalafil	1件: D02008 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	1件: 86 💬
546	Tamoxifen	Tamoxifen	2件: D00966, D08559 💬	2件: ESR1, ESR2 💬	9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway	4件:  2 , 86, 113, 227 💬
547	Tasigna	-	-	-	-	2件: 34, 86 💬
548	Tasigna®	-	-	-	-	1件: 86 💬
549	Tasigna® 150 mg	-	-	-	-	1件: 86 💬
550	Tbd	-	-	-	-	4件: 19, 86, 276, 299 💬
551	Tegaderm	-	-	-	-	1件: 86 💬
552	Terguride	Terguride	1件: D01348 💬	2件: DRD2, PRL 💬	12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway	2件: 51, 86 💬
553	Terguride 0,5mg tablet	Terguride	1件: D01348 💬	2件: DRD2, PRL 💬	12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway	1件: 86 💬
554	Terguride 0.5 mg tablet	Terguride	1件: D01348 💬	2件: DRD2, PRL 💬	12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway	1件: 86 💬
555	Tezosentan	Tezosentan	-	-	-	1件: 86 💬
556	The pop02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:	-	-	-	-	1件: 86 💬
557	The pops study is collecting pk data on children prescribed the following drugs of interest per standard of care:	-	-	-	-	1件: 86 💬
558	Thelin	-	-	-	-	1件: 86 💬
559	Threonine	Threonine	1件: D00041 💬	-	-	3件: 86, 96, 97 💬
560	Thrombin	Thrombin	1件: D00090 💬	-	-	2件: 86, 88 💬
561	Tocilizumab	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	18件:  2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
562	Tpn171h	-	-	-	-	1件: 86 💬
563	Traclear	-	-	-	-	1件: 86 💬
564	Tracleer	-	-	-	-	8件: 13, 51, 84, 85, 86, 88, 210, 211 💬
565	Tracleer 62,5 mg comprimidos recubiertos con película	-	-	-	-	1件: 86 💬
566	Tracleer 62,5mg 56cpr riv.	-	-	-	-	1件: 86 💬
567	Tracleer*125mg 56cpr riv.	-	-	-	-	2件: 51, 86 💬
568	Tracleer*56cpr riv 125mg	-	-	-	-	3件: 51, 86, 88 💬
569	Tracleer®	-	-	-	-	1件: 86 💬
570	Transdihydrolisuride	-	-	-	-	2件: 51, 86 💬
571	Tre	-	-	-	-	1件: 86 💬
572	Treprosinil diethanolamine	-	-	-	-	1件: 86 💬
573	Treprostin	-	-	-	-	1件: 86 💬
574	Treprostinil	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	6件: 51, 84, 85, 86, 88, 210 💬
575	Treprostinil dietanolamina	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
576	Treprostinil diethanolamine	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	2件: 51, 86 💬
577	Treprostinil diolamine	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
578	Treprostinil inhalation powder	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
579	Treprostinil inhalations	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
580	Treprostinil injectable product	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
581	Treprostinil sodium	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	3件: 51, 86, 88 💬
582	Treprostinil sodium solution for inhalation	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
583	Treprostinil sodium, ut-15	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
584	Treprostinil, ut-15, lrx-15, 15au81, bw a15au, u-62, 840	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
585	Treprostinilo	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
586	Trimetazidine	Trimetazidine	2件: D01606, D08642 💬	-	-	2件: 58, 86 💬
587	Trk-100stp	-	-	-	-	1件: 86 💬
588	Tyrosine	Tyrosine	1件: D00022 💬	-	-	3件:  6 , 86, 111 💬
589	Tyvaso	-	-	-	-	1件: 86 💬
590	Tyvaso inhalation solution	-	-	-	-	1件: 86 💬
591	Ubenimex	Ubenimex	1件: D00087 💬	1件: ANPEP 💬	4件: Glutathione metabolism, Hematopoietic cell lineage, Metabolic pathways, Renin-angiotensin system	1件: 86 💬
592	Udenafil	Udenafil	1件: D10027 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	2件: 86, 210 💬
593	Uk 092480	-	-	-	-	1件: 86 💬
594	Uk-92,480	-	-	-	-	1件: 86 💬
595	Uk-92,480-10	-	-	-	-	1件: 86 💬
596	Uptravi	-	-	-	-	3件: 84, 86, 88 💬
597	Ut-15c	-	-	-	-	1件: 86 💬
598	Ut-15c (treprostinil diethanolamine)	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
599	Ut-15c 0.25 mg	-	-	-	-	1件: 86 💬
600	Ut-15c 1 mg	-	-	-	-	1件: 86 💬
601	Ut-15c 5 mg	-	-	-	-	1件: 86 💬
602	Ut-15c lp	-	-	-	-	1件: 86 💬
603	Ut-15c sr	-	-	-	-	2件: 51, 86 💬
604	Ut-15c sr (treprostinil diethanolamine)	Treprostinil	1件: D06213 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
605	Ut-15c-sr	-	-	-	-	2件: 51, 86 💬
606	Vardenafil	Vardenafil	3件: D02731, D03260, D08668 💬	1件: PDE5A 💬	3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	3件: 13, 86, 299 💬
607	Vasomera (pb1046) injection	-	-	-	-	1件: 86 💬
608	Veletri	-	-	-	-	1件: 86 💬
609	Ventavis	-	-	-	-	1件: 86 💬
610	Ventavis (iloprost, bayq6256)	Iloprost	1件: D02721 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
611	Ventavis 10	-	-	-	-	1件: 86 💬
612	Ventavis(iloprost)	Iloprost	1件: D02721 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 86 💬
613	Viagra	-	-	-	-	3件: 86, 96, 225 💬
614	Vip	-	-	-	-	3件: 49, 51, 86 💬
615	Volibris	-	-	-	-	4件: 51, 85, 86, 88 💬
616	Volibris 10 mg comprimidos recubiertos con película	-	-	-	-	1件: 86 💬
617	Volibris 5 mg comprimidos recubiertos con película	-	-	-	-	1件: 86 💬
618	Volibris® (ambrisentan)	Ambrisentan	1件: D07077 💬	1件: EDNRA 💬	7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 86 💬
619	Volibris™ tablets	-	-	-	-	1件: 86 💬
620	Zamicastat	Zamicastat	-	-	-	1件: 86 💬

先頭へ